| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Insider buying and selling activity across 203 companies in the Health Care Equipment & Supplies industry. Part of the Health Care sector.
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Mar 2, 2023 | NVCR Novocure Ltd | Cordova Ashley75 | Chief Financial Officer | Sell | 1,055 | $75.28 | $79,418.18 | -1.1% | -4.4% | -78.4% | |
| Mar 2, 2023 | NVCR Novocure Ltd | Groenhuysen Wilhelmus Cm65 | Chief Operating Officer | Sell | 1,213 | $75.28 | $91,312.09 | -0.7% | -4.4% | -78.4% | |
| Mar 2, 2023 | NVCR Novocure Ltd | Shah Pritesh75 | Chief Growth Officer | Sell | 937 | $75.28 | $70,535.39 | -0.9% | -4.4% | -78.4% | |
| Mar 2, 2023 | MMSI Merit Medical Systems Inc | Parra Raul Jr.62 | CFO And Treasurer | Sell | 11,986 | $70.00 | $839,020.00 | -60.9% | +17.9% | +9.1% | |
| Mar 2, 2023 | LMAT Lemaitre Vascular Inc | Jasinski Lawrence J62 | Director | Sell | 192 | $50.00 | $9,600.00 | -2.0% | +23.4% | +32.7% | |
| Mar 2, 2023 | NVCR Novocure Ltd | Burke William Patrick62 | Chief Human Resources Officer | Sell | 281 | $75.28 | $21,153.09 | -0.4% | -4.4% | -78.4% | |
| Mar 2, 2023 | KIDS Orthopediatrics Corp | Hauser Joseph W60 | Sr VP &Gm Trauma &Deformity | Sell | 2,554 | $43.74 | $111,704.81 | -6.6% | -0.3% | -35.2% | |
| Mar 2, 2023 | NVCR Novocure Ltd | Leonard Frank X76 | President, Cns Cancers Us | Sell | 4,107 | $75.38 | $309,577.72 | -3.4% | -4.4% | -78.4% | |
| Mar 2, 2023 | RBOT Vicarious Surgical Inc. | Liang Philip45 | Director | Buy | 30,000 | $2.60 | $77,952.00 | +10.4% | -18.6% | -85.8% | |
| Mar 2, 2023 | AORT Artivion, Inc. | Davis John E | Senior VP, Global Sales | Sell | 1,121 | $13.41 | $15,034.63 | -0.9% | +8.1% | +37.2% | |
| Mar 2, 2023 | AORT Artivion, Inc. | Maney Rochelle L. | VP, Quality | Sell | 821 | $13.41 | $11,011.09 | -2.7% | +8.1% | +37.2% | |
| Mar 2, 2023 | AORT Artivion, Inc. | MacKin James P53 | President &CEO | Sell | 9,990 | $13.41 | $133,983.88 | -1.8% | +8.1% | +37.2% | |
| Mar 2, 2023 | AORT Artivion, Inc. | Stanton Marshall S.51 | SVP, Clinical &MD Affair | Sell | 907 | $13.41 | $12,164.50 | -1.7% | +8.1% | +37.2% | |
| Mar 2, 2023 | AORT Artivion, Inc. | Getz Matthew A | VP, Human Resources | Sell | 702 | $13.41 | $9,415.08 | -1.9% | +8.1% | +37.2% | |
| Mar 2, 2023 | BSX Boston Scientific Corp | Brennan Daniel J.47 | EVP And CFO | Sell | 105,610 | $46.65 | $4,926,250.98 | -18.0% | +9.0% | +42.1% | |
| Mar 2, 2023 | CNMD Conmed Corp | Jonas Daniel S72 | Special Counsel &Corp Secy | Sell | 10,400 | $96.16 | $1,000,104.00 | -27.0% | +24.5% | -17.9% | |
| Mar 2, 2023 | AORT Artivion, Inc. | Lee David Ashley46 | Executive VP, COO &CFO | Sell | 1,401 | $13.41 | $18,789.93 | -0.4% | +8.1% | +37.2% | |
| Mar 2, 2023 | AORT Artivion, Inc. | Green Andrew M | VP Regulatory | Sell | 825 | $13.41 | $11,064.73 | -3.1% | +8.1% | +37.2% | |
| Mar 2, 2023 | AORT Artivion, Inc. | Maier Dennis B50 | SVP, Operations | Sell | 1,121 | $13.41 | $15,034.63 | -2.2% | +8.1% | +37.2% | |
| Mar 2, 2023 | AORT Artivion, Inc. | Holloway Jean F49 | SVP, General Counsel | Sell | 907 | $13.41 | $12,164.50 | -0.7% | +8.1% | +37.2% | |
| Mar 2, 2023 | AORT Artivion, Inc. | Horton Amy48 | VP, Chief Accounting Officer | Sell | 702 | $13.41 | $9,415.08 | -0.6% | +8.1% | +37.2% | |
| Mar 2, 2023 | MMSI Merit Medical Systems Inc | Lampropoulos Fred P67 | President And CEO | Sell | 20,659 | $69.88 | $1,443,684.67 | -1.0% | +17.9% | +9.1% | |
| Mar 1, 2023 | ARAY Accuray Inc | Hoge Michael68 | Senior VP Global Operations | Sell | 11,977 | $2.89 | $34,613.53 | -2.3% | +25.8% | -9.4% | |
| Mar 1, 2023 | DXCM Dexcom Inc | Sayer Kevin R62 | President CEO And Chairman Of | Sell | 38,464 | $109.94 | $4,228,611.36 | -5.4% | +2.5% | +3.9% | |
| Mar 1, 2023 | LUNG Pulmonx Corp | Sung Derrick81 | Chief Financial Officer | Sell | 1,264 | $11.03 | $13,941.92 | -0.2% | +0.3% | -19.7% |
The blue line has two modes, toggled with the Relative and Absolute buttons:
Relative (default) shows cumulative industry performance with both the overall market and parent sector movements removed. When the line rises above 100, the industry is outperforming its sector; below 100 means underperforming. This is calculated using factor returns via weighted least squares (WLS) regression, isolating pure industry-specific behavior.
Absolute shows the total cumulative return of the industry including market and sector movement. This reflects what an investor actually experienced — an industry can show strong absolute gains even while underperforming its sector in relative terms.
Both views start at an index of 100. Other return drivers such as momentum, value, or size are deliberately retained in both modes, since these are part of what makes an industry behave the way it does and may reflect the conditions insiders are responding to.